ATPC vs USNA

For growth investors, USANA Health Sciences, Inc.

(USNA) is the stronger pick with 8. 3% revenue growth year-over-year, versus -7. 6% for Agape ATP Corporation (ATPC). USANA Health Sciences, Inc. (USNA) offers the better valuation at 33. 6x trailing P/E (11. 2x forward), making it the more compelling value choice. Analysts rate USANA Health Sciences, Inc. (USNA) a "Hold" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, USANA Health Sciences, Inc.

(USNA) delivered a total return of -80. 0%, compared to -100. 0% for Agape ATP Corporation (ATPC). Over 10 years, the gap is even starker: USNA returned -68. 7% versus ATPC's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Agape ATP Corporation (ATPC) is the lower-risk stock at -2.

01β versus USANA Health Sciences, Inc. 's 1. 34β — meaning USNA is approximately -167% more volatile than ATPC relative to the S&P 500. On balance sheet safety, USANA Health Sciences, Inc. (USNA) carries a lower debt/equity ratio of 2% versus 19% for Agape ATP Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), USANA Health Sciences, Inc.

(USNA) is pulling ahead at 8. 3% versus -7. 6% for Agape ATP Corporation (ATPC). On earnings-per-share growth, the picture is similar: USANA Health Sciences, Inc. grew EPS -73. 5% year-over-year, compared to -21. 7% for Agape ATP Corporation. Over a 3-year CAGR, ATPC leads at 9. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

USANA Health Sciences, Inc.

(USNA) is the more profitable company, earning 1. 2% net margin versus -186. 8% for Agape ATP Corporation — meaning it keeps 1. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: USNA leads at 5. 5% versus -194. 5% for ATPC. At the gross margin level — before operating expenses — USNA leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Agape ATP Corporation (ATPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -2.

01)). Both have compounded well over 10 years (ATPC: -100. 0%, USNA: -68. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.